Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:
“Dr. Joachim Aerts offers a prediction on the future of 1L immunotherapy for NSCLC at ITCD2025.
Excitement about bispecific antibiotics including ivonescimab.
Will cancer vaccines make an impact here?”
